TY - JOUR
KW - clinical trials
KW - epidemiology
KW - statistics & research methods
KW - vascular medicine
AU - P. Baptiste
AU - A. Wong
AU - A. Schultze
AU - M. Cunnington
AU - J. Mann
AU - C. Clase
AU - C. Leyrat
AU - L. Tomlinson
AU - K. Wing
AD - Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK paris.baptiste1@lshtm.ac.uk.
Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Epidemiology, Value & Evidence Outcomes, GlaxoSmithKline Research and Development Welwyn, Stevenage, UK.
Department of Medicine 4, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Germany.
KfH-Nierenzentrum, München-Schwabing, Germany.
Department of Medicine and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
AN - 35260450
BT - BMJ Open
C2 - PMC8905982
DO - 10.1136/bmjopen-2021-051907
DP - NLM
ET - 2022/03/10
LA - eng
M1 - 3
N1 - 2044-6055
Baptiste, Paris J
Orcid: 0000-0002-2565-8525
Wong, Angel Y S
Schultze, Anna
Cunnington, Marianne
Mann, Johannes F E
Clase, Catherine
Leyrat, Clémence
Tomlinson, Laurie A
Wing, Kevin
Journal Article
BMJ Open. 2022 Mar 8;12(3):e051907. doi: 10.1136/bmjopen-2021-051907.
PY - 2022
SN - 2044-6055
EP - e051907
T2 - BMJ Open
TI - Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial
VL - 12
ER -